Swimmer's Shoulder/Impingement Syndrome Market

Market Overview:

The 7 major swimmer's shoulder/impingement syndrome markets are expected to exhibit a CAGR of 5.7% during 2024-2034.

The swimmer's shoulder/impingement syndrome market has been comprehensively analyzed in IMARC's new report titled "Swimmer's Shoulder/Impingement Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Swimmer's shoulder, also known as shoulder impingement, subacromial impingement, or painful arc, refers to a type of shoulder tendinitis characterized by the inflammation of tendons and tissues that connect muscles to bones. The tendons in the shoulder become inflamed and swollen due to the pressing of nearby bones, muscles, or other tendons. Repetitive use of the joint creates irritation, inflammation, tears, and scarring, which are the main causes of the disorder. Inflammation usually affects the tendons of the rotator cuff, which can pressure the acromion, the top part of the shoulder blade bone. Additionally, friction on the shoulder blade can cause bone growth in the body. One of the common symptoms includes sudden pain in the shoulder when the person lifts the arm overhead or backward and faces issues in moving the joint smoothly. Other symptoms are shoulder weakness and instability, mild but persistent arm discomfort, and muscular fatigue. The diagnosis of the ailment consists of a physical examination and a review of symptoms. Various shoulder areas are also pressed to check for pain, bruising, or soreness, along with the shoulder's range of motion and mobility. Further, imaging exams are used to detect severe bone or soft tissue injuries. X-ray checks for broken or dislocated bones, and a CT scan or MRI reveals tendon tears, which help to diagnose the condition and prescribe treatment and drugs.

The rising prevalence of sports-related shoulder injuries across all age groups owing to the growing health consciousness and the elevating importance of physical activities is primarily driving the swimmer's shoulder/impingement syndrome market. Numerous sports requiring high or vigorous shoulder motion, such as swimming, tennis, basketball, etc., increase the risk of developing this syndrome. In addition to this, the expanding geriatric population, who are more susceptible to injuries related to soft tissues owing to age-related degeneration, is further creating a positive outlook for the market. Moreover, the emerging popularity of the minimally invasive arthroscopic technique, commonly known as shoulder arthroscopy, which relies on very small incisions to preserve joint mobility and function, is also bolstering the market growth. Besides this, several key players are making significant investments in developing corticosteroid injections to lessen acute pain and improve shoulder mobility. This, in turn, is further acting as another growth-inducing factor. Additionally, the widespread adoption of suture anchor devices on account of their strength of fixation and the support they provide to the injury site, is expected to drive the swimmer's shoulder/impingement syndrome market in the coming years.

IMARC Group's new report provides an exhaustive analysis of the swimmer's shoulder/impingement syndrome market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for swimmer's shoulder/impingement syndrome and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the swimmer's shoulder/impingement syndrome market in any manner.

Time Period of the Study

• Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2034

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
   

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the swimmer's shoulder/impingement syndrome market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the swimmer's shoulder/impingement syndrome market
• Reimbursement scenario in the market
• In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current swimmer's shoulder/impingement syndrome marketed drugs and late-stage pipeline drugs.

In-Market Drugs

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
   

Late-Stage Pipeline Drugs

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug Uptake and Market Performance

Key Questions Answered in this Report:

Market Insights

• How has the swimmer's shoulder/impingement syndrome market performed so far and how will it perform in the coming years?
• What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
• What was the country-wise size of the swimmer's shoulder/impingement syndrome market across the seven major markets in 2023 and what will it look like in 2034?
• What is the growth rate of the swimmer's shoulder/impingement syndrome market across the seven major markets and what will be the expected growth over the next ten years?
• What are the key unmet needs in the market?
   

Epidemiology Insights

• What is the size of the swimmer's shoulder/impingement syndrome patient pool (2018-2023) across the seven major markets?
• What would be the forecasted patient pool (2024-2034) across the seven major markets?
• What are the key factors driving the epidemiological trend of swimmer's shoulder/impingement syndrome?
• What will be the growth rate of patients across the seven major markets?
   

Swimmer's shoulder/impingement syndrome: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

• What are the current marketed drugs and what are their market performance?
• What are the key pipeline drugs and how are they expected to perform in the coming years?
• How safe are the current marketed drugs and what are their efficacies?
• How safe are the late-stage pipeline drugs and what are their efficacies?
• What are the current treatment guidelines for swimmer's shoulder/impingement syndrome drugs across the seven major markets?
• Who are the key companies in the market and what are their market shares?
• What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the swimmer's shoulder/impingement syndrome market?